blood stem cells
Showing 9976 - 10000 of >10,000
MDS Trial in Saint Louis (vosaroxin, Azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes
-
Saint Louis, MissouriWashington University School of Medicine
Mar 23, 2022
Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)
Withdrawn
- Leukemia
- Stem Cell Transplantation
-
Munich, Bavaria, Germany3. Medizinische Klinik, Klinikum rechts der Isar der TU München
Dec 5, 2022
Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)
Recruiting
- Solid Tumor, Adult
- +4 more
- KRAS-EphA-2-CAR-DC
- +3 more
-
Beijing, Beijing, ChinaBiotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022
Brain and CNS Tumors Trial in Los Angeles (therapeutic autologous dendritic cells)
Completed
- Brain and Central Nervous System Tumors
- therapeutic autologous dendritic cells
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020
AML, Adult Trial in Italy (IDH mutation test performed at diagnosis or relapse until January 31st, 2019.)
Completed
- AML, Adult
- IDH mutation test performed at diagnosis or relapse until January 31st, 2019.
-
Alessandria, Italy
- +23 more
Dec 31, 2021
Metabolism of Prostaglandin D2 Trial in Nashville (dietary supplement, drug, other)
Enrolling by invitation
- Metabolism of Prostaglandin D2
- niacin
- +2 more
-
Nashville, TennesseeVanderbilt University
Jan 25, 2022
Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Recurrent Anaplastic Large Cell Lymphoma
Recruiting
- Anaplastic Large Cell Lymphoma
- +19 more
- Pembrolizumab
- Pralatrexate
-
Duarte, California
- +2 more
Aug 15, 2022
Covid19, type1diabetes Trial in Esbjerg
Recruiting
- Covid19
- type1diabetes
-
Esbjerg, DenmarkHospital of South West Jutland
Mar 16, 2022
Coagulopathy in Acute Aortic Syndrome
Recruiting
- Coagulopathy
-
Paris, FranceUniversité de Paris
Nov 25, 2021
Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic
Terminated
- Recurrent B Acute Lymphoblastic Leukemia
- +3 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Apr 28, 2022
Hepatocellular Carcinoma Trial in Nanjing (hypovolemic phlebotomy)
Recruiting
- Hepatocellular Carcinoma
- hypovolemic phlebotomy
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Jun 1, 2023
Cold Urticaria, Cold Contact Urticaria, Symptomatic Dermographism Trial in Berlin (CDX-0159)
Active, not recruiting
- Cold Urticaria
- +4 more
-
Berlin, GermanyCharite University
Dec 20, 2022
Lung Cancer, Thoracic Surgery, Video-Assisted, Lobectomy Trial in Heerlen (Preoperative 3D lung reconstruction created with
Completed
- Lung Cancer
- +5 more
- Preoperative 3D lung reconstruction created with open-source software
-
Heerlen, Limburg, NetherlandsZuyderland Medical Center
Nov 9, 2023
Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)
Recruiting
- Sickle Cell Disease
- Etavopivat Tablets Low dose
- +3 more
-
Birmingham, Alabama
- +77 more
Oct 11, 2022
Crohn Disease, Ulcerative Colitis Trial (Adalimumab-680LT, Control)
Not yet recruiting
- Crohn Disease
- Ulcerative Colitis
- Adalimumab-680LT
- Control
- (no location specified)
Oct 30, 2023
Hidradenitis Suppurativa (HS) Trial in Lyon (Skin Swab & Skin Biopsies & Blood Sample)
Not yet recruiting
- Hidradenitis Suppurativa (HS)
- Skin Swab & Skin Biopsies & Blood Sample
-
Lyon, Rhône, FranceDepartment of Dermatology-Hôpital Edouard Herriot
Feb 9, 2023
Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Active, not recruiting
- Fallopian Tube Clear Cell Adenocarcinoma
- +26 more
- Clinical Observation
- +4 more
-
Birmingham, Alabama
- +314 more
Sep 28, 2021
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Terminated
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +8 more
- cytarabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 28, 2022
Samples From People With Unanticipated Response, Significant
Enrolling by invitation
- Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
C3PI Study Testing Group Trial in Kannapolis (Tasso-SST on Demand, Regular Phlebotomy)
Completed
- C3PI Study Testing Group
- Tasso-SST on Demand
- Regular Phlebotomy
-
Kannapolis, North CarolinaDuke CTSI Translational Population Health Office
Jul 5, 2022
Multiple Sclerosis Trial in Genova (7-day Fasting-Mimicking Diet (7-DAY FMD))
Active, not recruiting
- Multiple Sclerosis
- 7-day Fasting-Mimicking Diet (7-DAY FMD)
-
Genova, ItalyOspedale San Martino
Sep 8, 2023
HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou
Recruiting
- HIV Infection
- Combined Antiretroviral Therapy
-
Hangzhou, Zhejiang, ChinaZhikai Wan
Aug 30, 2023